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A B S T R A C T
A longitudinal study was conducted to investigate the presence of multidrug antimicrobial resistance
(multi-AR) in Salmonella enterica in pigs reared under conventional preventative medicine programmes
in Spain and the possible association of multi-AR with ceftiofur or tulathromycin treatment during the
pre-weaning period. Groups of 7-day-old piglets were treated by intramuscular injection with ceftiofur
on four farms (n = 40 piglets per farm) and with tulathromycin on another four farms (n = 40 piglets per
farm). A control group of untreated piglets (n = 30 per farm) was present on each farm. Faecal swabs were
collected for S. enterica culture prior to treatment, at 2, 7 and 180 days post-treatment, and at slaughter.
Minimal inhibitory concentrations of 14 antimicrobial agents, pulsed-ﬁeld gel electrophoresis and
detection of resistance genes representing ﬁve families of antimicrobial agents were performed. Plasmids
carrying cephalosporin resistant (CR) genes were characterised. Sixty-six S. enterica isolates were
recovered from ﬁve of eight farms. Forty-seven isolates were multi-AR and four contained blaCTX-M genes
harboured in conjugative plasmids of the IncI1 family; three of these isolates were recovered before
treatment with ceftiofur. The most frequent AR genes detected were tet(A) (51/66, 77%), sul1 (17/66, 26%);
tet(B) (15/66, 23%) and qnrB (10/66,15%). A direct relation between the use of ceftiofur in these conditions
and the occurrence of CR S. enterica was not established. However, multi-AR was common, especially for
ampicillin, streptomycin, sulphonamides and tetracycline. These antibiotics are used frequently in
veterinary medicine in Spain and, therefore, should be used sparingly to minimise the spread of multi-AR.
© 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Salmonella enterica is a major foodborne pathogen, causing
infections in human beings and animals worldwide. In 2014,
89,873 conﬁrmed human cases of salmonellosis were reported in
the European Union (EU) (EFSA, 2017). Control programmes for S.
enterica in eggs and poultry have been effective in reducing the
number of salmonellosis cases in human beings (EFSA, 2014).
However, this trend is levelling out, owing to the persistence of S.
enterica in pigs and porcine products (Pires et al., 2011). On the
basis of examination of mesenteric lymph nodes of fattening pigs,
there is a wide range (0–36.4%) in the frequency of detection of S.* Corresponding author.
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1090-0233/© 2018 The Authors. Published by Elsevier Ltd. This is an open access article unenterica between countries in the EU (EFSA, 2015). In Spain, a major
producer of pigs in the EU, S. enterica was detected in 30% of pigs
(EFSA, 2015).
Vaccination of pigs against S. enterica serovars that are non-
pathogenic for pigs is not recommended, since pigs can be
asymptomatically infected and can transmit the bacteria to human
beings (San Román et al., 2013). S. enterica control programmes in
pigs are mainly based on hygiene/disinfection, biosecurity
measures and farm management practices. Treatment with
antimicrobial agents are necessary for control of clinical outbreaks
involving bacteria as primary or secondary pathogens, and have
been used as a metaphylactic and prophylactic tool when there is a
high probability of an outbreak of unknown bacterial aetiology
(Barton, 2014). The selective pressure exerted by antimicrobial
agents may contribute to the emergence of bacteria with
antimicrobial resistance (AR) (Garcia-Migura et al., 2014). Pigsder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Salmonella enterica serovars isolated from faeces at different intervals and treatments administered in each farm during the rearing cycle.
Farm Antimicrobial agents used at different post-birth intervals Sampling at different post-birth intervals
Number of isolates/number of samples analysed (%)
Number of serovars
Intramuscular (day 7) Pre-starter/starter 1 (days 21–49) Starter 2 (days 50–79) Day 7 Day 9 Day 14 Day 187
1 Untreated Amoxicillin
Colistin sulphate
NA 2/30 (7%)
2 Rissen
3/30 (10%)
3 Rissen
3/28 (11%)
3 Rissen
2/28 (7%)
2 Rissen
Tulathromycin 0/40 0/40 0/39 2/39 (5%)
2 Derby
Sows 0/7
3 Untreated Amoxicillin
Apramycin
Tiamulin
Oxytetracycline
Tiamulin
Oxytetracycline
1/30 (3%)
1 Panama
3/30 (10%)
3 Typhimurium
0/30 2/24 (8.3%)
2 Panama
Tulathromycin 2/40 (5%)
2 Panama
1/40 (2.5%)
1 Panama
0/40 3/36 (8.3%)
1 Panama
2 Typhimurium
Sows 1/7 (14.2%)
1 Typhimurium
6 Untreated 0/30 0/30 0/30 0/24
Tulathromycin 0/40 0/40 0/40 2/34 (5.8%)
1 Rissen
1 Typhimurium
Sows 0/7
7 Untreated 0/30 0/30 0/30 0/16
Tulathromycin 0/40 0/40 0/40 0/30
Sows 0/7
2 Untreated Amoxicillin
Apramycin
Tiamulin
Oxytetracycline
Tiamulin
Oxytetracycline
13/30 (43%)
2 Brandenburg
11 Rissena
4/30 (13%)
4 Rissena
1/30 (3.3%)
1 Rissen
1/22 (4.5%)
1 Typhimurium
Ceftiofur 7/40 (18%)
3 Anatuma
3 Rissena
1 Brandenburg
5/40 (13%)
3 Brandenburg
2 Rissen
1/38
1 Rissen
1/38 (2.6%)
1 Typhimurium
Sows 1/7 (14.2%)
1 Brandenburg
4 Untreated 0/30 0/30 0/30 0/18
Ceftiofur 0/40 0/40 0/40 0/35
Sows 0/7
5 Untreated 0/30 0/30 0/26 4/17 (24%)
4 Rissen
Ceftiofur 0/40 0/40 0/37 1/33 (3%)
1 Rissen
Sows 0/7
8 Untreated 0/29 0/29 0/21 0/21
Ceftiofur 0/37 0/36 0/34 0/0
Sows 0/7
Total strains 66 27/614 (4.4%) 16/555 (0.9%) 5/533 (0.9%) 18/415 (4.3%)
a A total of four cephalosporin resistant (CR) Salmonella enterica serovars were found. One S. Anatum isolates were obtained at day 7 in the cephalosporin treated group.
Three S. Rissen isolates were obtained in the untreated group (2 strains at day 7 and 1 strain at day 9). NA, not applicable.
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there is a risk of foodborne transmission to consumers through the
food chain.
Third and fourth generation cephalosporins, such as ceftiofur
and cefquinome, are licensed for the treatment of systemic
bacterial infections in pigs (Cameron-Veas et al., 2015). These
b-lactam antimicrobial agents are some of the most important
compounds used in human medicine, constituting the main
therapeutic choice for treatment of infections caused by Enter-
obacteriaceae (Collignon et al., 2009). The possible selection of
cephalosporin resistant (CR) S. enterica, together with concerns
relating to their entry into the food chain, has raised questions
regarding the use of these antimicrobial agents in pigs. In Spain,multi-AR was detected in 55% of S. enterica isolates in 2015 (EFSA,
2017).
This longitudinal study was undertaken to evaluate the
presence of multi-AR S. enterica on conventional pig farms in
Spain that use antimicrobial agents in their preventative medicine
programmes. b-Lactam antimicrobial agents (penicillins and
cephalosporins) and macrolides (tulathromycin and tildipirosin)
are the most commonly prescribed drugs in pigs during the
suckling period in Spain (Moreno, 2014). The aim of this study was
to assess the effect of ceftiofur and tulathromycin treatment on the
emergence of CR S. enterica during the pre-weaning period, and in
the S. enterica population in pigs from day 7 until slaughter. The
genotypic and phenotypic diversity of the S. enterica serovars
obtained from each of the farms were analysed. Since
Fig. 1. Dendrogram illustrating XbaI-pulse ﬁeld gel electrophoresis (PFGE) proﬁles and antimicrobial resistance phenotype of Salmonella enterica (n = 66) isolated from faeces
of fattening pigs in Catalonia, Spain. Black squares represent resistance. A, Ampicillin (wild type, WT, 8 mg/L); C, chloramphenicol (WT  16 mg/L); S, streptomycin
(WT  16 mg/L); Su, sulphamethoxazole (WT  64 mg/L); T, tetracycline (WT  8 mg/L); Ctx, cefotaxime (WT  0.25 mg/L); Caz, ceftazidime (WT  0.5 mg/L); Ci, ciproﬂoxacin
(WT  0.064 mg/L); Na, nalidixic acid (WT  16 mg/L); G, gentamicin (WT  2 mg/L); K, kanamycin (WT  8 mg/L); F, ﬂorfenicol (WT  16 mg/L); Cs, colistin (WT  2 mg/L);
Tm, trimethoprim (WT  2 mg/L). Codes of isolates (Id Lab) were based on the numbers assigned to the farm (G), visit number (V) and pig number (C).
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of choice for treatment of human salmonellosis, the presence of
genes coding for these antimicrobial agents was assessed.
Materials and methods
Study design
This study was approved by the Animal Care and Ethics Committee of the
University of Lleida, Spain (approval number DAAM7684; date of approval 12October 2012). This was a longitudinal study on S. enterica prevalence carried out
on a cohort of eight farms located in Catalonia, Spain. Sampling was carried out at
the same time as a study on Escherichia coli published by Cameron-Veas et al.
(2016). None of the farms had a history of cephalosporin use for at least 2 years
prior to the study. The sampling period started in November 2012 and ﬁnished in
May 2014. Seventy 7-day-old piglets (seven separate litters per farm) were ear
tagged in both ears for identiﬁcation throughout the study period. This sample size
was based on an estimated prevalence of S. enterica shedders of at least 40%
(Casanova-Higes et al., 2017). An increment of at least 30% of animals excreting AR
bacteria after treatment was considered to be substantive. On the basis of these
numbers, the sample size selected for the study was 32 animals in each of the
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power of 80%.1
Farms were randomly divided into two groups of four farms each, according
to the antimicrobial treatment administered for experimental purposes, i.e.
ceftiofur or tulathromycin. Within each farm, one group of 7-day-old pigs
(n = 40) was treated with either ceftiofur (Naxcel, Zoetis; 5 mg/kg of body weight)
or tulathromycin (Draxxin, Zoetis; 2.5 mg/kg of body weight), administered by a
single intramuscular injection (Cameron-Veas et al., 2016). The remaining
selected pigs from each farm (n = 30) were kept as an untreated control group.
In most cases, the groups remained separated in distant pens over the study
period, including during transportation to the ﬁnishing farm; the exception was
farm 2, which was managed under a farrow-to-ﬁnish cycle system. Most farms
belonged to the same large integration system; the exception was farm 1, which
was owned by an independent farmer. During the rearing period, all pigs were fed
under a standard nutritional programme (see Appendix: Supplementary Table 1)
set by the companies, including the prophylactic use of antimicrobial agents
(Table 1), from days 21 (weaning) to 49 (pre-starter and starter 1 feeds), as well
as from days 50 to 70 (starter 2 feed). Of the 560 animals selected for inclusion in
the study, 164 were not sampled at some point due to either death or loss of ear
tags (Table 1).
Faecal samples were collected from 7-day-old piglets (day 7) before treatment
with tulathromycin or ceftiofur, as detailed in Table 1, at days 9 and 14 of life, and
immediately before the animals were sent for slaughter (day 187  2 days). On day 7,
faecal samples were also collected from the respective sows (n = 7 per farm).
Salmonella enterica culture and characterisation
Faecal samples were taken from the rectum of each pig and transported to the
laboratory at 4 C on the same day of sampling. On receipt, 5 g of faeces from each
animal were homogenised in 25 mL buffered peptone water and incubated at 37 C
for 24 h. After incubation, 0.1 mL homogenate were inoculated onto Rappaport-
Vassiliadis semisolid medium and incubated at 42 C for 24 and 48 h (the latter if
negative at 24 h), followed by streaking 1 mL on XLT4 medium with and without
ceftriaxone (1 mg/L). Culture media were from Merck and antibiotics were from
Sigma–Aldrich. One S. enterica isolate from each positive sample was selected for
conﬁrmation and serotyping at the Laboratori Agroalimentari, Departament
d’Agricultura, Ramaderia, Pesca, Alimentació i Medi Natural, Cabrils, Spain, by
the reference slide agglutination method, for speciﬁc somatic ﬂagella and capsular
antigens, using the Kauffmann–White scheme (Popoff et al., 2004).
Antimicrobial susceptibility testing
Minimal inhibitory concentrations (MICs) of 14 antimicrobial agents were
determined using the broth microdilution method (VetMIC GN-mo, Swedish
National Veterinary Institute) using ampicillin, chloramphenicol, streptomycin,
sulphamethoxazole, tetracycline, cefotaxime, ceftazidime, ciproﬂoxacin, nalidixic
acid, gentamicin, kanamycin, ﬂorfenicol, colistin and trimethoprim (Fig. 1) (Sola-
Gines et al., 2015). Epidemiological cut-off values were determined according to
recommendations of the European Committee on Antimicrobial Susceptibility
Testing (EUCAST).2 Multidrug resistance was deﬁned as resistance to antibiotics of
at least three different families (Schwarz et al., 2010).
Two double disc combinations (cefotaxime with cefotaxime/clavulanic acid and
ceftazidime with ceftazidime/clavulanic acid) were used to conﬁrm the extended
spectrum b-lactamase (ESBL) phenotype. Synergy was deﬁned as an increase in
zone diameter  5 mm. Cefoxitin was used for the detection of ampC-type
b-lactamase (CLSI, 2008).
Antimicrobial resistant genetic determinants
Resistance to cephalosporins was assessed by PCR for blaTEM, blaCTXM, blaCMY-1,
blaCMY-2 and blaSHV (Hasman et al., 2005). Sequence analysis was performed using
Vector NTI advance 11 (InforMax). The ampliﬁed nucleotide sequences were
compared to those in the National Center for Biotechnology Information (NCBI) data
base using BLAST.3
Isolates exhibiting low susceptibility to ciproﬂoxacin were tested for the
plasmid-mediated quinolone resistance genes (PMQRs) qnrA, qnrB, qnrC, qnrD and
qnrS (Wasyl, 2014). The presence of resistance genes for the aminoglycosides aadA,
strA/strB, aac(3)IV, aadB, aphA1 and aphA2, the tetracyclines tet(A), tet(B) and tetC),
and the sulphonamides sul1, sul2 and sul3 were also tested by PCR (Kozak et al.,
2009).1 See: http://epitools.ausvet.com.au/content.php?page=home (accessed 18 Jan-
uary 2017).
2 See: http://www.eucast.org/ (accessed 18 January 2017).
3 See: www.ncbi.nlm.nih.gov (accessed 18 January 2017).Pulsed ﬁeld gel electrophoresis and plasmid characterisation
To assess the clonality of the strains and the epidemiological relatedness within
farms, XbaI pulsed ﬁeld gel electrophoresis (PFGE) macro-restriction was
performed using a Chef-DR II System (Biorad) (Ribot et al., 2006). PFGE proﬁles
were compared using Fingerprinting II Informatixe software (Applied Maths).
Isolates were considered to have a unique pattern when at least one band difference
was detected (Liebana et al., 2002). Bands were analysed using the Dice coefﬁcient
and unweighted pair group method with arithmetic averages (optimisation 1.5%
and position tolerance 1.5%).
Replicons from plasmids with an ESBL phenotype were characterised by PCR-
based replicon typing (Carattoli et al., 2005). Filter mating experiments using the
rifampicin resistant E. coli strain HB101, together with plasmid DNA extraction and
electroporation, were performed as described by Cameron-Veas et al. (2015).
Transconjugants were selected on Luria–Bertani (LB) agar plates containing
rifampicin (100 mg/L) and ceftriaxone (1 mg/L). The presence of a unique plasmid
in each transconjugant harbouring the cephalosporin resistant gene was conﬁrmed
and their sizes were determined using S1-nuclease digestion, followed by PFGE
(Barton et al., 1995).
Statistical analysis
McNemar’s test (paired samples) was used to evaluate whether the prevalence
of S. enterica and CR S. enterica in the different herds differed between consecutive
sampling times for a given treatment (ceftiofur or tulathromycin) (Kirkwood and
Sterne, 2003). The x2 test was used to assess whether the prevalence of S. enterica
differed among herds or treatments at a given sampling time. When the number of
observations for one of the categories was small (i.e. <5), Fisher’s exact test was
used (Kirkwood and Sterne, 2003). Statistical analyses were carried out using SAS
version 9.1.3 (IBM) and the signiﬁcance level was set at P < 0.05.
Results
Occurrence of Salmonella enterica
A total of 2117 faecal samples were collected during the course
of the study. Sixty-six (3.1%) samples were positive for S. enterica;
these were obtained from ﬁve out of the eight farms sampled
(Table 1). On the ﬁve positive farms, 27 isolates were obtained from
day 7, 16 from day 9, ﬁve from day 14 and 18 from day 187  2. CR S.
enterica was detected on one farm (farm 2; Table 1), prior to
ceftiofur administration (3/21 isolates) and at day 9 (1/9 isolates).
No signiﬁcant differences were observed in the prevalence of CR S.
enterica between consecutive sampling times after treatment with
ceftiofur.
The prevalence of S. enterica at day 7 was higher (P < 0.01) on
farm 2 (20/70, 28.6%) than on the remaining farms (2/70, 2.8%). On
farm 2, prior to antimicrobial treatment, the untreated control
group had a higher prevalence of S. enterica (13/30, 43%) than that
of the ceftiofur treated group (7/40, 17.5%; P = 0.018). Thereafter,
the prevalence of S. enterica in the untreated group reduced
signiﬁcantly (P < 0.01) to 13% of shedders at day 9 in both
untreated and treated groups (4/30 and 5/40, respectively)
(Table 1). A signiﬁcant reduction (P < 0.05) in S. enterica shedding
was observed from days 7 to 14 for both the untreated and treated
groups. On farm 5, signiﬁcant differences (P = 0.022) in S. enterica
prevalence were found, at day 187, between pigs treated with
ceftiofur (1/33, 3.0%) and untreated pigs (4/17, 24%) (Table 1). S.
enterica was isolated from sows on 2/8 farms, as well as in their
offspring; serovars were the same between sows and piglets on
farm 2, but different on farm 3.
Among the 66 isolates of S. enterica, the most prevalent serovar
was Rissen (38/66, 58%), followed by the monophasic variant of
Typhimurium (9/66, 14%), then Panama and Brandenburg (7/66,
11% each) (Table 1). The ﬁrst two were the most widely distributed
serovars, since they were present in four and three of the positive
farms, respectively.
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As shown in Fig. 1, S. enterica isolates exhibited resistance to
tetracycline (98%), ampicillin (58%), sulphamethoxazole (53%),
streptomycin (58%), ciproﬂoxacin (50%), trimethoprim (32%),
gentamicin (20%), chloramphenicol (20%) and nalidixic acid
(15%). Twelve percent of the isolates were resistant to ﬂorfenicol
and 4% were resistant to kanamicin. None of the isolates exhibited
resistance to colistin. Forty-seven isolates were multidrug resis-
tant, being resistant to at least 3/14 antimicrobial agents tested,
and exhibiting 19 different antimicrobial resistance proﬁles.
Among these isolates, 38/66 (57.6%) were resistant to at least
four antimicrobial classes, with 31/38 (81.6%) isolates resistant
simultaneously to ampicillin (A), streptomycin (S), sulphonamides
(Su) and tetracycline (T) alone or in combination with other
antimicrobial agents, thus exhibiting the ASSuT multidrug resis-
tant proﬁle (Table 2). In the case of the S. Typhimurium
monophasic stain, ASSuT is associated with a resistance region
localised on the bacterial chromosome. Furthermore, 16/18 (89%)
isolates recovered before the animals were slaughtered were
multi-resistant. Only one isolate (serovar Rissen) was pan-
susceptible (Fig. 1). Four isolates (three S. Rissen and one S.
Anatum from farm 2) were resistant to cephalosporins (Table 2).Table 2
Phenotypic and genotypic characterisation of antimicrobial resistance proﬁles of the Salm
by serovars.
Serovars Phenotypea (number of isolates) Genotype (n
Rissen (38) ACSSuTCiNaGTm (1) 
ASSuTTm (5) 
ASTTm (1) 
ATCtxCazCiNa (1) 
ATCtxCazCi (1) 
ATCi (2) 
ATCtxCazCiNaTm (1) 
TCiNa (1) 
STCi (4) 
TCi (9) 
TCCi (1) 
TCiF (1) 
TGF (1) 
T (7) 
SuT (1) 
Pan-susceptible (1) 
Typhimurium monophasic (9) ASSuTCi (1) 
ASSuTG (1) 
ACSSuTGTm (1) 
ASuTG (1) 
ASSuTTm (1) 
ASSuT (4) 
Brandenburg (7) ACSSuTCiNaGFTm (5) aadA/strA/B/t
ACSSuT (1) 
CSSuTTm (1) 
Panama (7) ASSuTCi (1) 
ASSuTCiTm (1) 
ASSuTGK (2) 
ASSuT (2) 
ASSuTK (1) 
Anatum (3) CSSuTCiTm (1) 
ACSSuTCiNaGFTm (1) 
ACSSuTCtxCazCiTm (1) 
Derby (2) ASSuTTm (1) 
ASSuT (1) 
Ctx, cefotaxime and ceftazidime; aminoglycosides: aadA, strA/strB, aac(3)IV, aadB, a
quinolones: qnrA, qnrB, qnrB, qnrD, qnrS; b-lactams: blaCTX-M, blaCMY, blaSHV.
a See Fig. 1 for antimicrobial nomenclature.The most prevalent antimicrobial genotypes were tet(A) (77%),
sul1 (27%) and tet(B) (23%) (Table 2). The qnrB gene was detected in
10 (15%) isolates among four serovars, namely Brandenburg (n = 5),
Anatum and Rissen (n = 2 each), and Panama (n = 1) (Table 2); nine
of these isolates were recovered from the same farm (farm 2),
while S. Panama was recovered from Farm 3 (Fig. 1).
Resistance to cephalosporin in isolates from farm 2 was
associated with the presence of blaCTX-M-1 and blaCTX-M-14 genes
in two different S. Rissen isolates, and blaCTX-M-1 in one isolate of S.
Anatum recovered from three 7-day old piglets. An additional S.
Rissen blaCTX-M-1 was isolated from the same animal in the second
visit (at day 9); this animal belonged to the control group (Table 1).
CR S. enterica was not detected during further visits to this farm. All
isolates harbouring CTX-M transferred the genes to the recipient
strain by conjugation and transformation. In all cases, CTX-M genes
were harboured in a 95 kilobase plasmid belonging to the IncI1
incompatibility group.
Macro-restriction analysis using XbaI produced 12–16 bands
and distributed the 66 isolates into eight major clusters consisting
of isolates with related PFGE proﬁles (80% identity) and three
unique PFGE patterns represented by a single isolate each (Fig. 1).
PFGE analysis demonstrated high clonality between S. enterica
isolates of the same serovar within farms. Indistinguishableonella enterica isolates (numbers in curved brackets) obtained in this study, grouped
umber of isolates)
tet(A) (1)
tet(A)/sul1 (2); aadA/tet(A)/sul1 (2); aadA/aac(3)IV/tet(A)/sul1(1)
tet(A) (1)
tet(A)/blaCTX-M (1)
tet(A)/blaCTX-M (1)
tet(A) (2)
tet(A)/blaCTX-M (1)
tet(A) (1)
tet(A) (4)
tet(A)/qnrB (2); tet(A) (7)
tet(A) (1)
tet(A) (1)
tet(A) (1)
tet(A) (6); tet(A)/sul1(1)
tet(A) (1)
Not found
tet(B)/sul2 (1)
tet(B)/sul2 (1)
tet(B)/su1/sul2l (1)
tet(A) (1)
tet(B) (1)
tet(B)/sul2 (2); tet(B)(2)
et(A)/sul1/qnrB (1); tet(A)/sul1/sul3/qnrB (3); aadA/strA/B/tet(A)/sul1/sul2/qnrB (1)
tet(A)/sul1 (1)
tet(A)/sul1 (1)
tet(B) (1)
tet(B)/qnrB (1)
aphA1/tet(B) (2)
tet(B) (2)
tet(B) (1)
tet(A)/sul1 (1)
aadA/strA/B/tet(A)/sul1/qnrB (1)
tet(A)/sul1/qnrB/blaCTX-M (1)
aadA/tet(A)/sul1 (1)
aadA/tet(A)/sul1 (1)
phA1, aphA2; tetracycline: tet(A), tet(B), tet(C); sulphonamides: sul1, sul2, sul3;
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from isolates obtained at different sampling times, indicating the
persistence of clones over time. Two of the S. Rissen isolates
resistant to cephalosporin recovered from the farm 2 had identical
PFGE patterns (E3G2V1C7R and E3G2V1C50R; Fig. 1).
Discussion
A common practice in preventative medicine programmes
among large pig producers of Spain is to inject 7-day old piglets
with one intramuscular dose of ceftiofur during the lactation
period. In the longitudinal study carried out on conventional farms,
we found no evidence of a direct effect from this practice on the
emergence of CR S. enterica strains. This conclusion could be
inﬂuenced by the low prevalence of S. enterica and the low number
of CR strains found in the farms studied, as well as by the wide
variety of serovars isolated, since different serovars show different
abilities to acquire resistance genes (Aarestrup, 2004).
In the four CR isolates recovered from farm 2, CTX-M genes
were harboured on a conjugative plasmid of 95 kb, belonging to the
IncI1 family of replicons (Rodriguez et al., 2009; Zurﬂuh et al.,
2014). Farm 2 also had a high prevalence of CR E. coli during the
study period associated with the same group of plasmids
(Cameron-Veas et al., 2016). The presence of these CR strains in
both treated and untreated cephalosporin groups suggests an
exchange of mobile genetic elements between the different
Enterobacteriaceae could have occurred in this farm. Moreover,
we found that most of S. enterica strains (especially those
recovered on the last visit to the farm and before the animals
were sent) exhibited multi-AR and belonged to S. enterica serovars
frequently associated with human infections (EFSA, 2011). This
ﬁnding highlights the importance of human infections from pig
products if these multi-AR strains enter the food chain.
Although gastroenteritis caused by non-typhoidal S. enterica is
mostly self-limiting and treatment is not required, 5% of the
individuals will develop bacteraemia, which is potentially fatal and
requires antibiotic treatment (Anjum et al., 2011). In these cases,
the recommended drugs of choice are ﬂuoroquinolones and
cephalosporins. Nowadays, the treatment of many infectious
diseases, in both humans and animals, relies upon just one or
two drugs (Woolhouse and Farrar, 2014). A restrictive policy of
antibiotic usage should be implemented in livestock in the EU, in
order to protect human health.
The quinolone resistance gene qnrB was detected in different S.
enterica serotypes coexisting in the same farm. Resistance to
tetracycline was frequent and was correlated with the presence of
tet(A) and tet(B) genes. Additionally, resistance to aminoglycosides
encoded by aphA1, aadA and aac(3)IV was also present. As
demonstrated in Table 1, at least four families of antimicrobial
agents (b-lactams, polymyxins, aminoglycosides and tetracy-
clines) were administered during the rearing cycle on all of the
conventional farms included in this study, as usually occurs on
intensive pig farms (Moreno, 2014; EMA, 20154). In this study, a
high number of isolates exhibited a multi-AR phenotype to
streptomycin, ampicillin and sulphonamides, which are antimi-
crobial agents commonly use in veterinary medicine. Unfortu-
nately, details of the types, frequencies and doses/routes of
antimicrobial agents used on the farms studied was not available to
determine the possible relationship between antibiotic adminis-
tration and the presence of the multi-AR resistant strains. To
address this concern, it would be desirable to carry out further4 EMA, 2015. http://www.ema.europa.eu/docs/en_GB/document_library/Report/
2015/10/WC500195687.pdf (date accessed 13 December 2017).studies, including farms where antimicrobial agents have never
been or are infrequently used.
The most frequent serovar obtained in this study was Rissen,
followed by Typhimurium monophasic (4,(5),12:i:-). In Europe, the
prevalence of S. Typhimurium monophasic (4,(5),12:i:-) causing
foodborne outbreaks and its presence in pigs and pork products
have been increasing (Hopkins et al., 2010; EFSA, 2011).
Additionally, the two major clones (labelled as Spanish and
European clones) circulating in Europe show multi-AR resistance
to four different antimicrobial families, i.e. ampicillin, streptomy-
cin, sulphonamide and tetracycline (ASSuT family proﬁle) (Garcia
et al., 2014). In this study, the nine S. Typhimurium monophasic
strains exhibited the ASSuT phenotype (Table 2), and ﬁve (i.e.
E3G3V4C17, E3G3V4C19, E3G2V4C25, E3G2V4C63 and
E3G6V4C13; Fig. 1) were recovered just before the animals were
slaughtered. Continuous surveillance should be implemented to
understand the molecular mechanisms and the environmental
forces driving the emergence and spread of these clonal lines.
Conclusions
Multi-AR resistant S. enterica was present on pig farms in Spain
using preventative veterinary programmes for the treatment of
infectious diseases, but a direct effect between the emergence of
these multi-AR strains and antimicrobial treatments regularly used
on these farms was not observed. The presence of AR genes in S.
enterica from pigs was conﬁrmed as being associated to
transferrable plasmids.
Conﬂict of interest statement
None of the authors of this paper has any ﬁnancial or personal
relationship with other people or organisations that could
inappropriately inﬂuence or bias the content of the paper.
Acknowledgments
This work was supported by project AGL2011-28836 from the
Ministerio de Economia y Competitividad of Spain, the Departa-
mento de Innovación, Empresa y Empleo del Gobierno de Navarra
(project reference IIQ14064.RI1) and Fundación Caja Navarra,
Spain (project reference VATC 2014-0411 y VATC 2015-70628).
Contract of LMG was supported by the Instituto Nacional de
Investigación y Tecnología Agraria y Alimentaria (INIA) and the
European Social Fund. Contract of VG was supported by Fundación
Caja Navarra, Spain (project reference VATC 2015-70628). We
acknowledge the Centres de Recerca de Catalunya programme for
ﬁnancial support, and to John G. Wild for review of English.
Appendix: Supplementary material
Supplementary data associated with this article can be found, in
the online version, at https://doi.org/10.1016/j.tvjl.2018.02.002.
References
Aarestrup, F.M., 2004. Monitoring of antimicrobial resistance among food animals:
principles and limitations. Journal of Veterinary Medicine. B. Infectious
Diseases and Veterinary Public Health 51, 380–388.
Anjum, M.F., Choudhary, S., Morrison, V., Snow, L.C., Mafura, M., Slickers, P., Ehricht,
R., Woodward, M.J., 2011. Identifying antimicrobial resistance genes of human
clinical relevance within Salmonella isolated from food animals in Great Britain.
Journal of Antimicrobial Chemotherapy 66, 550–559.
Barton, B.M., Harding, G.P., Zuccarelli, A.J., 1995. A general method for detecting and
sizing large plasmids. Analytical Biochemistry 226, 235–240.
Barton, M.D., 2014. Impact of antibiotic use in the swine industry. Current Opinion
in Microbiology 19, 9–15.
42 K. Cameron-Veas et al. / The Veterinary Journal 234 (2018) 36–42Cameron-Veas, K., Moreno, M.A., Fraile, L., Migura-Garcia, L., 2016. Shedding of
cephalosporin resistant Escherichia coli in pigs from conventional farms after
early treatment with antimicrobials. The Veterinary Journal 211, 21–25.
Cameron-Veas, K., Sola-Gines, M., Moreno, M.A., Fraile, L., Migura-Garcia, L., 2015.
Impact of the use of b-lactam antimicrobials on the emergence of Escherichia
coli isolates resistant to cephalosporins under standard pig-rearing conditions.
Applied Environmental Microbiology 81, 1782–1787.
Carattoli, A., Bertini, A., Villa, L., Falbo, V., Hopkins, K.L., Threlfall, E.J., 2005.
Identiﬁcation of plasmids by PCR-based replicon typing. Journal of
Microbiological Methods 63, 219–228.
Casanova-Higes, A., Andres-Barranco, S., Mainar-Jaime, R.C., 2017. Inﬂuence of on-
farm pig Salmonella status on Salmonella shedding at slaughter. Zoonoses and
Public Health 64, 328–336.
CLSI, 2008. Performance Standards for Antimicrobial Susceptibility Testing.
Eighteenth Informational Supplement. M100-S18, vol. 28. Clinical and
Laboratory Standards Institute (CLSI), Wayne, PA, USA, 181 pp.
Collignon, P., Powers, J.H., Chiller, T.M., Aidara-Kane, A., Aarestrup, F.M., 2009. World
Health Organization ranking of antimicrobials according to their importance in
human medicine: a critical step for developing risk management strategies for
the use of antimicrobials in food production animals. Clinical Infectious
Diseases 49, 132–141.
EFSA, 2011. The European Union summary report on antimicrobial resistance in
zoonotic and indicator bacteria from humans, animals and food in the European
Union in 2009. European Food Safety Authority (EFSA)/European Centre for
Disease Prevention and Control (ECDC). EFSA Journal 9, 2154.
EFSA, 2014. The European Union summary report on trends and sources of
zoonoses, zoonotic agents and food-borne outbreaks in 2012. European Food
Safety Authority (EFSA)/European Centre for Disease Prevention and Control
(ECDC). EFSA Journal 12, 3547.
EFSA, 2015. The European Union summary report on trends and sources of
zoonoses, zoonotic agents and food-borne outbreaks in 2013. European Food
Safety Authority (EFSA)/European Centre for Disease Prevention and Control
(ECDC). EFSA Journal 13, 3991.
EFSA, 2017. The European Union summary report on trends and sources of zoonoses,
zoonotic agents and food-borne outbreaks in 2014. European Food Safety
Authority (EFSA)/European Centre for Disease Prevention and Control (ECDC).
EFSA Journal 15, 4694.
Garcia-Migura, L., Hendriksen, R.S., Fraile, L., Aarestrup, F.M., 2014. Antimicrobial
resistance of zoonotic and commensal bacteria in Europe: the missing link
between consumption and resistance in veterinary medicine. Veterinary
Microbiology 170, 1–9.
Garcia, P., Hopkins, K.L., Garcia, V., Beutlich, J., Mendoza, M.C., Threlfall, J., Mevius, D.,
Helmuth, R., Rodicio, M.R., Guerra, B., 2014. Diversity of plasmids encoding
virulence and resistance functions in Salmonella enterica subsp. enterica serovar
Typhimurium monophasic variant 4,[5],12:i:- strains circulating in Europe.
Public Library of Science One 9, e89635.
Hasman, H., Mevius, D., Veldman, K., Olesen, I., Aarestrup, F.M., 2005. b-Lactamases
among extended-spectrum b-lactamase (ESBL)-resistant Salmonella from
poultry, poultry products and human patients in The Netherlands. Journal of
Antimicrobial Chemotherapy 56, 115–121.
Hopkins, K.L., Kirchner, M., Guerra, B., Granier, S.A., Lucarelli, C., Porrero, M.C.,
Jakubczak, A., Threlfall, E.J., Mevius, D.J., 2010. Multiresistant Salmonella entericaserovar 4,[5],12:i:- in Europe: a new pandemic strain? Eurosurveillance.
European Communicable Disease Bulletin 15, 19580.
Kirkwood, B.R., Sterne, J.A.C., 2003. Essential Medical Statistics, 2nd ed. Blackwell
Science, Oxford, UK 512 pp.
Kozak, G.K., Boerlin, P., Janecko, N., Reid-Smith, R.J., Jardine, C., 2009. Antimicrobial
resistance in Escherichia coli isolates from swine and wild small mammals in the
proximity of swine farms and in natural environments in Ontario, Canada.
Applied Environmental Microbiology 75, 559–5566.
Liebana, E., Crowley, C.J., Garcia-Migura, L., Breslin, M.F., Corry, J.E., Allen, V.M.,
Davies, R.H., 2002. Use of molecular ﬁngerprinting to assist the understanding
of the epidemiology of Salmonella contamination within broiler production.
British Poultry Science 43, 38–46.
Moreno, M.A., 2014. Survey of quantitative antimicrobial consumption per
production stage in farrow-to-ﬁnish pig farms in Spain. Veterinary Record Open
1, e000002.
Pires, S.M., de Knegt, L., Hald, T., 2011. Estimation of the Relative Contribution of
Different Food and Animal Sources to Human Salmonella Infections in the
European Union. Scientiﬁc/Technical Report submitted to the European Food
Safety Authority (EFSA), Question Number EFSA-Q-2010-00685, 80 pp. http://
onlinelibrary.wiley.com/doi/10.2903/sp.efsa.2011.EN-184/epdf (accessed 18
January 2017).
Popoff, M.Y., Bockemühl, J., Gheesling, L.L., 2004. Supplement 2002 (no. 46) to the
Kauffmann–White scheme. Research in Microbiology 155, 568–570.
Ribot, E.M., Fair, M.A., Gautom, R., Cameron, D.N., Hunter, S.B., Swaminathan, B.,
Barrett, T.J., 2006. Standardization of pulsed-ﬁeld gel electrophoresis protocols
for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for
PulseNet. Foodborne Pathogens and Disease 3, 59–67.
Rodriguez, I., Barownick, W., Helmuth, R., Mendoza, M.C., Rodicio, M.R., Schroeter,
A., Guerra, B., 2009. Extended-spectrum b-lactamases and AmpC b-lactamases
in ceftiofur-resistant Salmonella enterica isolates from food and livestock
obtained in Germany during 2003–07. Journal of Antimicrobial Chemotherapy
64, 301–309.
San Román, B., Garrido, V., Grilló, M.J., 2013. Non typhoidal salmonellosis. In: Giese,
M. (Ed.), Molecular Vaccines: From Prophylaxis to Therapy, vol. 1. Springer-
Verlag, Vienna, Austria, pp. 329–342.
Schwarz, S., Silley, P., Simjee, S., Woodford, N., van Duijkeren, E., Johnson, A.P.,
Gaastra, W., 2010. Assessing the antimicrobial susceptibility of bacteria
obtained from animals. Journal of Antimicrobial Chemotherapy 65, 601–604.
Sola-Gines, M., Gonzalez-Lopez, J.J., Cameron-Veas, K., Piedra-Carrasco, N., Cerda-
Cuellar, M., Migura-Garcia, L., 2015. Houseﬂies (Musca domestica) as vectors for
extended-spectrum b-lactamase-producing Escherichia coli on Spanish broiler
farms. Applied Environmental Microbiology 81, 3604–3611.
Wasyl, D., 2014. Prevalence and characterization of quinolone resistance
mechanisms in commensal Escherichia coli isolated from slaughter animals in
Poland, 2009–2012. Microbial Drug Resistance 20, 544–549.
Woolhouse, M., Farrar, J., 2014. Policy: an intergovernmental panel on antimicrobial
resistance. Nature 509, 555–557.
Zurﬂuh, K., Jakobi, G., Stephan, R., Hachler, H., Nuesch-Inderbinen, M., 2014.
Replicon typing of plasmids carrying bla CTX-M-1 in Enterobacteriaceae of
animal, environmental and human origin. Frontiers in Microbiology 5, 555.
